Dr. David Radin
Co-founder & Managing Director
Attended the University of California Berkley where he obtained a Ph.D. in genetics in 1976. His roles includes setting and managing scientific goals as well as overseeing the planning and completion of BioStrategies’ scientific and commercialization goals. David has over 20 years experience conducting research aimed at developing plant-based protein biologics expression for use as therapeutics in rare diseases.
Dr. Carole cramer
Co-founder & Scientific Director
Dr. Cramer is internationally recognized as a pioneer in plant-based bioproduction of complex therapeutic proteins with more than 30 years of experience in R&D. She was the first to demonstrate that plants can successfully produce bioactive human lysosomal enzymes including glucocerebrosidase and iduronidase (patent issued in 1999) and has led the development of lectin-mediated delivery to address key bottleneck in efficacy of enzyme replacement therapeutics. She is co-founder and chief scientific officer of BioStrategies and professor emeritus at Arkansas State University. She was founding Director of the multi-institutional Arkansas Center for Plant-Powered Production (2007-2015). Dr. Cramer served on the inaugural Biotech Industry Organization Committee on Plant-Made Pharmaceuticals and was appointed by the US Secretary of Agriculture to serve 2 terms on the Biotechnology and 21st Century Agriculture (AC21) committee. Her education includes a BA from the University of California, Berkeley, a PhD in Molecular Biology and Biochemistry from UC Irvine, and postdoctoral experience at the Salk Institute in La Jolla, CA. She served on the faculty of Virginia Tech for 18 years prior to moving to Arkansas to head up A-State’s Biosciences Institute in 2004.